Advertisement

Topics

Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

08:40 EDT 22 Jun 2018 | Labiotech.eu

London-based Autolus has made its debut on the NASDAQ raising funds to boost the development of a next generation of CAR-T cell therapy for cancer.  Founded in 2014 as a spin-out from University College London, Autolus has been taking great strides to ...

The post Next-Generation CAR-T Company Raises €130M on NASDAQ IPO appeared first on Labiotech.eu.

Original Article: Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

NEXT ARTICLE

More From BioPortfolio on "Next-Generation CAR-T Company Raises €130M on NASDAQ IPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...